Omnia SanaPlant Comparison
Bitter Melon vs Olive
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Bitter Melon and Olive: they share 6 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Bitter Melon | Olive | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Blood sugar / diabetes support | 9/10 | 6/10 | Stronger for Bitter Melon |
| Cancer (anticancer research) | 9/10 | 2/10 | Stronger for Bitter Melon |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Olive |
| Metabolic support | 5/10 | 5/10 | Comparable evidence |
| Skin irritation | 1/10 | 5/10 | Stronger for Olive |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
The principal bioactive phenolics of the leaf, responsible for most of its antioxidant, anti-inflammatory and antihypertensive activity.
Antioxidant flavonoids of the leaf.
Pentacyclic triterpenes of the leaf cuticle and fruit skin, studied for anti-inflammatory and metabolic effects.
The dominant fatty acid of the fruit oil, a key component of the Mediterranean-diet lipid profile.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
Olive leaf extract may lower blood pressure; use caution if already on antihypertensive medication. May have mild hypoglycaemic effects. Olive oil is safe for dietary use. Rare olive pollen allergy. Well tolerated in normal culinary and supplement doses.
Duke (2002) includes olive leaf as ++ and notes hypotensive, hypoglycemic, ACE inhibitor-like, and antioxidant activities at the experimental level (score 1). Olive leaf extract (containing oleuropein) has demonstrated blood pressure-lowering and antiarrhythmic effects consistent with clinical support (PHR). Duke notes that traditional Mediterranean use for both the leaf and fruit is food-grade and safe. Olive leaf preparations are used as mild antihypertensives in European phytotherapy. No significant adverse effects are reported at standard herbal doses (Duke, 2002).
External Ids
Botanical Description
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Evergreen tree (Oleaceae), typically 3-15 m tall, often gnarled and long-lived, with some specimens surviving for centuries. Leaves are narrow, leathery, lance-shaped, dark green above and silvery-grey beneath. Small, fragrant, creamy-white four-lobed flowers are borne in axillary clusters, followed by a fleshy drupe (the olive) that ripens from green to purple-black.[1]
Habitat
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Native to the Mediterranean basin, the Near East and parts of Africa, and cultivated for millennia across Mediterranean-type climates worldwide (warm, dry summers and mild winters); tolerates poor, rocky, calcareous soils and drought.[1]
Harvesting
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Leaves can be harvested year-round from pruned or fallen branches, generally at their highest oleuropein content in late autumn and winter; fruit is hand- or machine-harvested from early autumn (green olives) through winter (fully ripe black olives), depending on the intended product.[10]
Traditional Uses
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Olive leaf and fruit have a long Mediterranean tradition as a tonic, antipyretic and mild antihypertensive remedy, and olive oil is the foundation fat of the traditional Mediterranean diet, long associated with cardiovascular health. Modern research on oleuropein and other leaf polyphenols supports antioxidant, anti-inflammatory, antimicrobial, blood-pressure-lowering and insulin-sensitising effects consistent with these traditional and dietary uses.[1, 4, 7]
Preparations
Dosage
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
A meta-analysis of trials for blood pressure used around 500 mg/day of standardised olive leaf extract. Educational reference only, not a prescription; culinary olive oil and leaf tea are considered food-safe at normal dietary amounts.
References
Drug Class Interactions
Lookalikes Review
Pairings
Not documented
Olive leaf and black seed (Nigella sativa) can each mildly lower blood pressure, so taking them together — especially alongside blood-pressure medicines — may add up and lower blood pressure more than expected. Monitor your blood pressure.[11, 18]
References & Sources
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
- Omar, S.H., Kerr, P.G., Scott, C.J., Hamlin, A.S. and others (2017) 'Olive (Olea europaea L.) Biophenols: A Nutriceutical against Oxidative Stress in SH-SY5Y Cells', Molecules, 22(11), pp. 1858. doi:10.3390/molecules22111858 Preclinical
https://doi.org/10.3390/molecules22111858 - Ruzzolini, J., Peppicelli, S., Andreucci, E., Bianchini, F. and others (2018) 'Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies', Nutrients, 10(12), pp. 1950. doi:10.3390/nu10121950 Preclinical
https://doi.org/10.3390/nu10121950 - Al-Rimawi, F., Sbeih, M., Amayreh, M., Rahhal, B. and others (2024) 'Evaluation of the antibacterial and antifungal properties of oleuropein, Olea europaea leaf extract, and Thymus vulgaris oil', BMC Complementary Medicine and Therapies, 24(1), pp. 297. doi:10.1186/s12906-024-04596-x Preclinical
https://doi.org/10.1186/s12906-024-04596-x - Qabaha, K., Al-Rimawi, F., Qasem, A. and Naser, S.A (2018) 'Oleuropein Is Responsible for the Major Anti-Inflammatory Effects of Olive Leaf Extract', Journal of Medicinal Food, 21(3), pp. 302-305. doi:10.1089/jmf.2017.0070 Preclinical
https://doi.org/10.1089/jmf.2017.0070 - Pang, K.L., Lumintang, J.N. and Chin, K.Y (2021) 'Thyroid-Modulating Activities of Olive and Its Polyphenols: A Systematic Review', Nutrients, 13(2), pp. 529. doi:10.3390/nu13020529 Meta-analysis / review
https://doi.org/10.3390/nu13020529 - Kheirandish, F., Mosaffa, N., Tarahi, M.J. and Fallahi, S (2018) 'Olive (Olea europaea) leaf extract alters the cytokine profile of Leishmania major-infected macrophages: New insight into the underlying mechanism', Parasite Immunology, 40(4), pp. e12520. doi:10.1111/pim.12520 Preclinical
https://doi.org/10.1111/pim.12520 - de Bock, M., Derraik, J.G., Brennan, C.M., Biggs, J.B. and others (2013) 'Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial', PLoS One, 8(3), pp. e57622. doi:10.1371/journal.pone.0057622 Randomized trial
https://doi.org/10.1371/journal.pone.0057622 - Pasban-Aliabadi, H., Esmaeili-Mahani, S., Sheibani, V., Abbasnejad, M. and others (2013) 'Inhibition of 6-hydroxydopamine-induced PC12 cell apoptosis by olive (Olea europaea L.) leaf extract is performed by its main component oleuropein', Rejuvenation Research, 16(2), pp. 134-142. doi:10.1089/rej.2012.1384 Preclinical
https://doi.org/10.1089/rej.2012.1384 - Imperatrice, M., Lasfar, A., van Kalkeren, C.A.J. and Troost, F (2024) 'Olive Leaf Extract Supplementation Improves Postmenopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Parallel Study on Postmenopausal Women', Nutrients, 16(22), pp. 3879. doi:10.3390/nu16223879 Randomized trial
https://doi.org/10.3390/nu16223879 - de Bock, M., Thorstensen, E.B., Derraik, J.G., Henderson, H.V. and others (2013) 'Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract', Molecular Nutrition & Food Research, 57(11), pp. 2079-2085. doi:10.1002/mnfr.201200795 Preclinical
https://doi.org/10.1002/mnfr.201200795 - Ismail, M.A., Norhayati, M.N. and Mohamad, N (2021) 'Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis', PeerJ, 9, pp. e11173. doi:10.7717/peerj.11173 Meta-analysis / review
https://doi.org/10.7717/peerj.11173 - Boskov Hansen, H.C. et al (2012) 'Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease', 13(9), pp. 11628--11670. doi:10.3390/ijms150712323 Traditional / reference
https://doi.org/10.3390/ijms150712323 - Wainstein, J. et al (2012) 'Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats', 15(7), pp. 605--610. doi:10.1089/jmf.2011.0243 Randomized trial
https://doi.org/10.1089/jmf.2011.0243 - Waterman, E. and Lockwood, B (2007) 'Active components and clinical applications of olive oil', 12(4), pp. 331--342. Preclinical
https://scholar.google.com/scholar?q=Active%20components%20and%20clinical%20applications%20of%20olive%20oil - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - de Bock, M., Derraik, J.G.B., Brennan, C.M., Biggs, J.B., Morgan, P.E., Hodgkinson, S.C., Hofman, P.L. and Cutfield, W.S (2013) 'Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial', PLoS One, 8(3), pp. e57622. doi:10.1371/journal.pone.0057622 Randomized trial
https://doi.org/10.1371/journal.pone.0057622 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Sahebkar, A., Soranna, D., Liu, X., Thomopoulos, C., Simental-Mendia, L.E., Derosa, G., Maffioli, P. and Parati, G (2016) 'A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure', Journal of Hypertension, 34(11), pp. 2127-2135. doi:10.1097/HJH.0000000000001049 Meta-analysis / review
https://doi.org/10.1097/HJH.0000000000001049
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.